Effectiveness of Astym Treatment For de Quervain's Tenosynovitis

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

32 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-01-31

Study Completion Date

2019-04-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To determine if the addition of Astym treatment to traditional therapy produces a more positive outcome then traditional therapy alone for the treatment of de Quervain's tenosynvitis. Two groups will be examined with one group receiving traditional therapy and the other group receiving traditional therapy in addition to Astym treatment protocol.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Sinew Acupuncture for de Quervain's Tenosynovitis

NCT03472443

de Quervain's Tenosynovitis

COMPLETED NA

A Clinical Trial of Splinting for DeQuervain's Tenosynovitis

NCT00438191

DeQuervain's Tenosynovitis

COMPLETED

Splinting vs Exercise in De Quervain's Tenosynovitis

NCT06995534

Splints Exercise Therapy De Quervains Tenosynovitis +2 more

RECRUITING NA

Steroid Injection in De Quervain Tenosynovitis

NCT05261737

De Quervain Disease

UNKNOWN

Non-surgical Intervention for Carpal Tunnel Syndrome

NCT03360344

Carpal Tunnel Syndrome, Susceptibility to

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

de Quervain's Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Occupational therapy

Traditional therapy for de Quervain's Tenosynovitis

Group Type ACTIVE_COMPARATOR

Occupational therapy

Intervention Type OTHER

Occupational therapy for de Quervain's Tenosynovitis

Occupational therapy with ASTYM

Traditional therapy for de Quervain's Tenosynovitis plus ASTYM

Group Type EXPERIMENTAL

Occupational therapy with ASTYM

Intervention Type DEVICE

Occupational therapy for de Quervain's Tenosynovitis plus ASTYM

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Occupational therapy

Occupational therapy for de Quervain's Tenosynovitis

Intervention Type OTHER

Occupational therapy with ASTYM

Occupational therapy for de Quervain's Tenosynovitis plus ASTYM

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

i. Positive Finkelstein's test: The client will report pain over the first compartment of the extensor retinaculum when the thumb is tucked in the hand and deviated ulnarly.

ii. Persistent symptoms for \>3 wks which have not resolved after an additional 3 weeks of splinting

iii. A diagnosis by a physician of "de Quervain's", "fist compartment tenosynovitis", or "radial styloid tenosynovitis"

iv. Patients must agree and comply to a predetermined splinting regimen

Exclusion Criteria

i. History of cortical steroid injection to affected wrist and/or thumb

ii. History of previous wrist trauma to affected limb

iii. Comorbidity such as carpal tunnel syndrome (CTS), radial tunnel syndrome, osteoarthritis, rheumatoid arthritis, auto-immune disease or inflammatory conditions, lateral epicondylitis or tendinopathies

iv. Clotting deficits

v. Positive Cozen's sign which would indicate intersection syndrome

vi. Post-partum mothers \<6 months and pregnant women

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No